More on DGNOF
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.33 |
|
|||
| Open | $0.34 | ||||
| 52 Wk High | $0.05 | ||||
| 52 Wk Low | $0.02 | ||||
| Day High | $0.34 | ||||
| Day Low | $0.32 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 29,900 | ||||
- DIAGNOS to Hold its Annual General Meeting of Shareholders on September 30, 2026
- DIAGNOS Receives Saudi FDA Medical Device License for CARA System, Bringing AI-Assisted Retinal Image Analysis to Saudi Arabia
- DIAGNOS Receives Health Canada Medical Device Licence for CARA System, Bringing AI-Assisted Retinal Image Analysis to Canadian Optometrists
- Presenting on Emerging Growth Conference 94 Day 1 on July 15; Register to live stream
- DIAGNOS to Extend the Exercise Period of Stock Warrants
- DIAGNOS Announces Shares for Debt Settlement
- DIAGNOS Submits Modified and Updated Health Canada Licence Application for CARA System Platform
- DIAGNOS Announces Grant of Stock Options and Adoption of Semi-Annual Reporting
- Presenting on Emerging Growth Conference 93 Day 1 on June 10; Register to live stream
- Emerging Growth Research Releases Flash Report on DIAGNOS, Highlighting Regulatory Catalysts and Commercialization Potential for CARA AI Platform
Entities mentioned with DGNOF
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- Twitter | View Related Stories »
- John McCain | View Related Stories »
- Bitcoin | View Related Stories »
- Show More...
